U.S. Communications Stock News

Installed Building Products, Inc. ( NYSE:IBP ) just released its latest quarterly results and things are looking...

Boot Barn Holdings, Inc. ( NYSE:BOOT ) investors will be delighted, with the company turning in some strong numbers...

We wouldn't blame Blackbaud, Inc. ( NASDAQ:BLKB ) shareholders if they were a little worried about the fact that...

The analysts might have been a bit too bullish on Generac Holdings Inc. ( NYSE:GNRC ), given that the company fell...

Magnachip Semiconductor Corporation ( NYSE:MX ) shareholders won't be pleased to see that the share price has had a...

Anyone interested in Trustmark Corporation ( NASDAQ:TRMK ) should probably be aware that the Independent Director...

When you see that almost half of the companies in the Oil and Gas industry in the United States have price-to-sales...

Investors who take an interest in Norwegian Cruise Line Holdings Ltd. ( NYSE:NCLH ) should definitely note that the...

To the annoyance of some shareholders, Art's-Way Manufacturing Co., Inc. ( NASDAQ:ARTW ) shares are down a considerable...

The analysts covering Kinetik Holdings Inc. ( NYSE:KNTK ) delivered a dose of negativity to shareholders today, by...

What financial metrics can indicate to us that a company is maturing or even in decline? A business that's potentially...

The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...

Ever wondered if Investar Holding is trading for less than it’s really worth? Let’s dig into what the numbers and market buzz reveal about its current value. The stock has climbed 3.4% over the past month and is up 11.9% since the start of the year, signaling renewed investor interest and possibly shifting sentiment around its growth prospects. Recently, the company completed a strategic acquisition aimed at expanding its regional presence, which has caught the eye of both analysts and...

In November 2025, Eledon Pharmaceuticals presented results from its Phase 2 BESTOW trial of tegoprubart for the prevention of organ rejection in kidney transplant recipients at the American Society of Nephrology's Kidney Week Annual Meeting. Although the primary endpoint did not meet statistical significance, the drug showed a promising safety profile and higher kidney function in some key patient subgroups compared to standard tacrolimus therapy. We'll explore how tegoprubart's...

Earlier this month, Clean Energy Fuels Corp. reported third-quarter 2025 earnings with revenue of US$106.1 million, exceeding analyst expectations, while announcing expanded renewable natural gas (RNG) production and several new supply agreements with major fleet operators and infrastructure clients nationwide. The company also secured contracts for hydrogen fueling stations and highlighted commissioning of dairy RNG projects, pointing to diversification and growth in decarbonization...

Akero Therapeutics (AKRO) stock has been quietly trending higher this month, gaining roughly 16% despite little in the way of major news. Many investors are revisiting the company’s progress and recent momentum. See our latest analysis for Akero Therapeutics. Akero’s impressive 16% share price return this month builds on a strong year, with momentum clearly gaining steam. The stock has surged 92.5% year-to-date. While recent news has been quiet, long-term total shareholder returns have also...

Wondering if Gambling.com Group is a golden opportunity trading below its fair value, or if the recent turbulence has put the stock in the bargain bin? Let’s take a closer look at what is really behind the current price. Shares have slipped by 6.7% over the last week and are down a hefty 54.6% year-to-date, highlighting how much sentiment and perceived risk can shift for this stock. Ongoing discussions surrounding digital gambling legislation and increased competition in the affiliate...

SunOpta Inc. recently reported improved third quarter results, turning a profit, and raised its revenue guidance for 2025 to US$812 million–US$816 million, while also providing a 2026 revenue outlook of US$865 million–US$880 million. This upward revision in guidance, combined with year-over-year sales growth and positive earnings, highlights strengthened operations and management’s confidence in future performance despite a third quarter impairment charge. We’ll assess how SunOpta’s...

Cidara Therapeutics recently announced progress in its Phase 3 ANCHOR study for CD388, securing a US$45 million milestone payment from Janssen, a BARDA award valued up to US$339.2 million to support manufacturing, and receiving FDA Breakthrough Therapy designation. These updates highlight the growing validation and financial support behind CD388, a promising immunotherapeutic candidate for influenza prevention and serious diseases. We'll explore how the combination of clinical and funding...

Porch Group, Inc. recently reported third-quarter 2025 results, surpassing expectations with US$118.08 million in revenue, while raising its full-year adjusted EBITDA and gross profit guidance. This performance was driven by particularly strong results in the Insurance Services segment and management's emphasis on surplus growth and premium scaling, positioning the company for improved future profitability. We'll explore how the company’s upgraded financial outlook and insurance-driven...

Prelude Therapeutics (PRLD) is shaking up its strategy with news of a major exclusive option agreement with Incyte and a renewed focus on its KAT6A breast cancer program. The company is also pausing the SMARCA2 clinical effort. See our latest analysis for Prelude Therapeutics. Prelude’s string of announcements, including the Incyte partnership, SMARCA2 pause, and executive change, has made for a volatile stretch, with the stock tumbling 25% over the last week alone. Share price momentum...

Neptune Insurance Holdings (NP) has caught investor attention this week, with shares closing at $26.86 and posting a 6% gain for the day. The stock’s recent move stands out against a backdrop of mixed performance within the insurance sector. See our latest analysis for Neptune Insurance Holdings. With a 1-day share price return of 6.2% and a year-to-date gain of 8.3%, Neptune Insurance Holdings is showing signs of renewed momentum following a modest dip over the past month. The latest uptick...

Curious if Gogo is undervalued or just misunderstood? You are not alone in wondering if now could be a smart time to look closer at the stock. The share price has taken a hit lately, dropping 16% in just the past week and sliding nearly 17% over the last month, putting some growth-watchers on alert for both risk and potential upside. One of the drivers behind these moves is the recent announcement about Gogo's partnership expansions in inflight connectivity, which has grabbed the attention...

Chart Industries reported its third quarter 2025 earnings on October 29, 2025, showing sales of US$1.10 billion but moving from net income of US$69 million to a net loss of US$138.5 million compared to the same period last year. Despite higher revenues, the company's earnings update revealed a shift to losses, with losses per share replacing the previous year's profits. We'll explore how the shift from profit to net loss may shape the outlook for Chart Industries' investment...